Vertex · 3 weeks ago
NA Analytics & Reporting, Associate Director, Cystic Fibrosis
Boston, MA
Full-time
Hybrid
Senior Level, Lead/Staff, Director/Executive
$158K/yr - $237K/yr
8+ years expVertex is a global biotechnology company that invests in scientific innovation, and they are seeking an Associate Director for NA Cystic Fibrosis Analytics & Reporting. This role will provide analytics support for strategic commercial initiatives and lead the performance analytics, dashboards, and insights generation for the NA CF business.
Computer Software
Responsibilities
Work with CF BU stakeholders to identify existing or planned initiatives that would benefit from additional analytics support, and collaboratively create and execute analytics plans to deliver actionable insights
Design & operate an analytical engine to identify & quantify drivers, barriers, and opportunities in the market using advanced statistical / ML methodology
Lead commercial KPI tracking, reporting, and analytics processes end-to-end, with primary focus on US CF (e.g., working with IT partners to develop Power BI dashboards, prepare PPT presentations, or other similar materials)
Contribute to answering ad-hoc analytics questions as they arise from the BU and other stakeholders; work to understand questions and define appropriate data & analytics approaches
Develop and leverage deep understanding of available data sets, and work with partners to ingest, process, and analyze data for reporting and analytics
Generate and deliver actionable insights to key stakeholders, including collaborating with other analytical partners at Vertex
Work collaboratively with cross-functional stakeholders, including but not limited to US Marketing, Global Marketing, US Market Access, US Finance, and Commercial Sales Operations
Qualification
Required
Bachelor's Degree and 8 years of experience or Master's degree in a quantitative discipline (Engineering, Statistics, Economics, Finance, Science) or equivalent experience
8 years in biotech/pharmaceuticals in a quantitative role in Commercial / Corporate Strategy / BD, and/or 4 years in a relevant consulting role (management, strategic or economic consulting) post-MBA/PhD, with meaningful biotech/pharmaceuticals and quantitative decision support experience
Proficiency with complex Excel modeling, and analyzing and developing insights from large data sets, leveraging relevant tools such as SQL, python, SAS, VBA, etc
Proficiency working with wide array of commercial pharma data sets, including data sets such as IQVIA (or equivalent from different data vendor), patient claims data, and internally generated sales / marketing data (e.g. field call data from CRM)
Experience building and maintaining KPI reporting dashboards within the pharma/biotech industry, using tools such as Power BI
Strong analytical and business acumen: intellectual curiosity, motivation and ability to structure problems, diagnose issues and triangulate with multiple approaches while keeping sight of the 'big picture'
Experience working with senior leadership to support insights generation and communication, financial forecasting and analytics, and/or commercial launch planning
Ability to quickly and thoughtfully adapt to new and evolving business and planning needs
Benefits
Annual bonus
Annual equity awards
Overtime pay
Medical, dental and vision benefits
Generous paid time off
Educational assistance programs including student loan repayment
Generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex
Vendor intelligence that combs through your supplier, manufacturer, logistics data to detect where you're leaving money on the table.
2-10 employees
H1B Sponsorship
Vertex has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (27)
2024 (18)
2023 (7)
2022 (13)
2021 (5)
2020 (7)
Funding
Current Stage
Early StageCompany data provided by crunchbase